Brenda Y. Hernandez to Human papillomavirus 16
This is a "connection" page, showing publications Brenda Y. Hernandez has written about Human papillomavirus 16.
Connection Strength
0.735
-
Hernandez BY, Lynch CF, Chan OTM, Goodman MT, Unger ER, Steinau M, Thompson TD, Gillison M, Lyu C, Saraiya M. Human papillomavirus DNA detection, p16INK4a, and oral cavity cancer in a U.S. population. Oral Oncol. 2019 04; 91:92-96.
Score: 0.166
-
Coghill AE, Bellizzi AM, Lynch CF, Shiels MS, Selk FR, Gillison M, Hernandez BY, Chan OTM, Engels EA. Pathology Characterization and Detection of Human Papillomavirus Type 16 in Rectal Squamous Cell Carcinomas. Clin Gastroenterol Hepatol. 2019 09; 17(10):2129-2131.
Score: 0.163
-
Hernandez BY, Rahman M, Lynch CF, Cozen W, Unger ER, Steinau M, Thompson T, Saber MS, Altekruse SF, Goodman MT, Powers A, Lyu C, Saraiya M. p16(INK4A) expression in invasive laryngeal cancer. Papillomavirus Res. 2016 12; 2:52-55.
Score: 0.135
-
Alemany L, Saunier M, Alvarado-Cabrero I, Quir?s B, Salmeron J, Shin HR, Pirog EC, Guimer? N, Hernandez-Suarez G, Felix A, Clavero O, Lloveras B, Kasamatsu E, Goodman MT, Hernandez BY, Laco J, Tinoco L, Geraets DT, Lynch CF, Mandys V, Poljak M, Jach R, Verge J, Clavel C, Ndiaye C, Klaustermeier J, Cubilla A, Castellsagu? X, Bravo IG, Pawlita M, Quint WG, Mu?oz N, Bosch FX, de Sanjos? S. Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer. 2015 Jan 01; 136(1):98-107.
Score: 0.119
-
Mix JM, Saraiya M, Thompson TD, Querec TD, Greek A, Tucker TC, Peters ES, Lynch CF, Hernandez BY, Copeland G, Goodman MT, Unger ER. Prevalence of human papillomavirus genotypes in high-grade cervical precancer and invasive cervical cancer from cancer registries before and after vaccine introduction in the United States. Cancer. 2021 10 01; 127(19):3614-3621.
Score: 0.049
-
Lin C, Slama J, Gonzalez P, Goodman MT, Xia N, Kreimer AR, Wu T, Hessol NA, Shvetsov Y, Ortiz AP, Grinsztejn B, Moscicki AB, Heard I, Del Refugio Gonz?lez Losa M, Kojic EM, Schim van der Loeff MF, Wei F, Longatto-Filho A, Mbulawa ZA, Palefsky JM, Sohn AH, Hernandez BY, Robison K, Simpson S, Conley LJ, de Pokomandy A, van der Sande MAB, Dube Mandishora RS, Volpini LPB, Pierangeli A, Romero B, Wilkin T, Franceschi S, Hidalgo-Tenorio C, Ramautarsing RA, Park IU, Tso FK, Godbole S, D'Hauwers KWM, Sehnal B, Menezes LJ, Her?clio SA, Clifford GM. Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis. Lancet Infect Dis. 2019 08; 19(8):880-891.
Score: 0.042
-
Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, Copeland G, Cozen W, Peters ES, Huang Y, Saber MS, Altekruse S, Goodman MT. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 2015 Jun; 107(6):djv086.
Score: 0.032
-
Sinno AK, Saraiya M, Thompson TD, Hernandez BY, Goodman MT, Steinau M, Lynch CF, Cozen W, Saber MS, Peters ES, Wilkinson EJ, Copeland G, Hopenhayn C, Watson M, Lyu C, Unger ER. Human papillomavirus genotype prevalence in invasive vaginal cancer from a registry-based population. Obstet Gynecol. 2014 Apr; 123(4):817-21.
Score: 0.029